Next Meetings

June 14, 2018 10am - 4pm PT

LA Renaissance Airport Hotel
9620 Airport Blvd
Los Angeles, CA 90045

CTAF will convene to review ICER's report on CGRP inhibitors for prevention of migraine headaches.

To watch the live webcast, beginning at 10am PT, visit http://www.beaconliveweb.com/join?jrd=aWNlcjJ8OTc5Nzk3fElDRVJ8QXR0ZW5kZWV8IHwgfA


Psoriasis Condition Update

New England CEPAC
July 12, 2018 9am - 5pm ET

Champlain College
Communication & Creative Media (CCM) Building
375 Maple Street
Burlington, VT 05401

The New England CEPAC will convene to review ICER's condition update on therapies for plaque psoriasis. During this meeting, the Council will also review a report on elagolix for endometriosis.

Register

Endometriosis

New England CEPAC
July 12, 2018 9am - 5pm ET

Champlain College
Communication & Creative Media (CCM) Building
375 Maple Street
Burlington, VT 05401

The New England CEPAC will review ICER's report on elagolix for endometriosis.

Register

Amyloidosis

Midwest CEPAC
September 13, 2018 10am- 4pm CT

Chicago Marriott at Medical District/UIC

625 S Ashland Ave

Chicago, IL 60607

The Midwest CEPAC will deliberate and vote on ICER's report on threatments for hereditary transthyretin-related (hATTR) amyloidosis, a rare genetic condition characterized by nerve, heart, and eye damage that is currently treated through supportive measures alone. The Council will also review a report on therapies for prostate cancer during this meeting.


Prostate Cancer

Midwest CEPAC
September 13, 2018 10am-4pm CT

Chicago Marriott at Medical District/UIC

625 S Ashland Ave

Chicago, IL 60607

The Midwest CEPAC will deliberate and vote on evidence presented in ICER's report on anti-androgen drugs for high risk prostate cancer. During this meeting, the Council will also discuss ICER's review of treatments for amyloidosis .


October 25, 2018 10am-4pm PT

California Endowment Oakland Conference Center
2000 Franklin St.
Oakland, CA 94612

CTAF will convene to review ICER's assessment of therapies for hereditary angioedema.


Opioid Use Disorder

New England CEPAC
November 8, 2018 10am - 4pm ET

Newton Marriott
2345 Commonwealth Avenue
Newton, MA 02466

The New England CEPAC will convene to review evidence on medications for addiction treatment in opioid use disorder.


Asthma

Midwest CEPAC
November 29, 2018 10am-4pm CT

Midwest, TBD


January 31, 2019 10am-4pm PT

Midwest, TBD

The Midwest CEPAC will convene to review ICER's assessment of canakinumab for atherosclerosis.

Dates listed below are approximate.


past Meetings

May 2017
ICER

Orphan Drug Assessment and Pricing Summit

ICER hosted a multi-stakeholder policy summit to discuss methods for assessing the value of new drugs for rare conditions. The summit included discussion of how methods can be applied to recommend fair prices that reflect the value of orphan drugs to patients and the health system, to allow for broader insurance coverage for innovative new treatments.